Login / Signup

A Meta-Analysis and Cohort Study of Histopathologic and Clinical Outcomes in ANCA-Negative versus -Positive Vasculitis.

Lauren FloydAdam D MorrisMohamed E ElsayedAnamay H ShettyAnanya BaksiDuvuru GeethaAjay DhaygudeSandip Mitra
Published in: Kidney360 (2022)
Our findings demonstrate that ANCA-negative PIGN presents in younger patients, with fewer extrarenal manifestations and higher ESKD risk, despite a lack of difference in histopathology. This study provides the impetus for further research into the pathogenesis, treatment response, and duration of immunotherapy in ANCA-negative disease. We suggest that the absence of positive ANCA serology should not discourage treatment and for clinical trials to include patients who are ANCA negative.
Keyphrases
  • clinical trial
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • randomized controlled trial
  • smoking cessation
  • replacement therapy